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Background: Testis-expressed sequence 101 (TEX101) was found to be highly expressed in testis and involved in
acrosome reaction in previous studies. Recently, the metastasis suppressor function of TEX101 in cancer was
disclosed, but the comprehensive investigation of its expression has rarely been reported. In this study, the
expression features of TEX101 in normal human organs and seminoma were systematically analyzed.
Results: Immunohistochemistry demonstrated intense staining of TEX101 in human testis tissues; however, its
expression in 27 other types of normal human organs, including the ovary, was negligible. Higher expression of
TEX101 was observed in the spermatocytes and spermatids of the testis, but relatively lower staining was detected
in spermatogonia. Western blotting showed a single TEX101 band of 38 kDa in human testis, but it did not
correspond to the predicted molecular weight of its mature form at 21 KDa. Furthermore, we examined seminoma
tissues by immunohistochemistry and found that none of the 36 samples expressed TEX101.
Conclusions: Our data confirmed TEX101 to be a testis protein that could be related to the maturation process of
male germ cells. The lack of TEX101 in seminoma indicated its potential role in tumor progression. This
characteristic expression of TEX101 could provide a valuable reference for understanding its biological functions.
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Human testis-expressed sequence 101 (TEX101), also
known as testis-expressed sequence 101, is a recently
identified protein. The TEX101 gene is located on human
chromosome 19q13.2 and encodes 249 amino acids
including a secretion signal peptide (1–25 amino acids)
at its N-terminus. After the signal peptide and its C-
terminus (223–249 amino acids) are removed, TEX101 is
transformed into its mature form, presenting a molecular
weight of 21 kDa and an isoelectric point of 4.7. Bioinfor-
matics analysis shows that TEX101 is a membrane GPI-
anchored protein with a conserved UPAR/Ly6 domain,
indicating a similar protein structure as urokinase-type
plasminogen activator receptor (uPAR) [1].* Correspondence: goulantu@foxmail.com
1State Key Laboratory of Biotherapy/Collaborative Innovation Center for
Biotherapy, West China Hospital, Sichuan University, No. 1, Keyuan Road 4,
Gaopeng Street, Chengdu 610041, PR China
Full list of author information is available at the end of the article
© 2014 Shen et al.; licensee BioMed Central Lt
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.TEX101 was initially identified in mice and showed a
limited distribution with high expression in testis [2-4].
Subsequently, TEX101 in human testis was identified
using cDNA microarray [5] and found to be involved in
the acrosome reaction in the process of insemination [6].
The acrosome reaction occurs in the acrosome of the
sperm when it interacts with the egg and is important for
mammalian fertilization [7,8]. Because of its specific sig-
nificance in testis, TEX101 has been utilized as a bio-
marker for male infertility, and this was confirmed to
diagnose azoospermia by means of testicular biopsy by
Drabovich’s team [9]. More recently, the expression and
behavior of TEX101 in cancer were also investigated and
showed potential significance for cancer progression
[10-12]. YIN et al. found that TEX101 could bind to uPA/
uPAR complexes and interfere with the activities of uPA,
matrix metalloproteinases and cathepsin B, which re-
sulted in the reduction of extracellular matrix degradation
and consequent suppression of cancer invasion [13].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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confirm its precise expression profile. However, previ-
ous studies on the distribution of TEX101 mainly ana-
lyzed its mRNA level [11,14,15]. To date, systematic
analysis of TEX101 protein expression has rarely been
reported. In the present study, we thoroughly analyzed
the expression features of TEX101 in human tissue sec-
tions. We hope that the data from our systematic ana-
lysis provide a valuable reference for understanding the
functions of TEX101.Results and discussion
Limited distribution of TEX101 in testis
To elucidate the expression profile of TEX101, 28
types of normal human organs were collected and sub-
jected to immunohistochemistry with a high-quality
anti-TEX101 antibody. Analysis of the sections showed
that testis was the only organ in which TEX101 was
highly expressed (Figure 1). The staining for TEX101
was not detected in the other 27 types of organs, in-
cluding ovary (Figure 1). These results confirmed that
TEX101 was a testis-abundant protein. This marker
has been utilized to diagnose male infertility [16,17].Figure 1 Expression analysis of TEX101 in various human tissues. Imm
using a rabbit polyclonal antibody against TEX101. These organs covered a
esophagus, stomach, small intestine, colon, pancreas, salivary gland, ovary,
gland, parathyroid gland, adrenal gland, thymus gland, tonsil, larynx, cerebe
visualized using diaminobenzidine, and images were captured with a Leica
in the testis samples, but not in the other tissue samples, including ovary.Expression characteristics of TEX101 in testis
Further detailed analysis revealed the expression charac-
teristics of TEX101 in testis. The high magnification view
showed that the connective tissue beyond the seminifer-
ous tubules presented negative staining for TEX101. Al-
though TEX101 presented very strong staining in the
seminiferous tubules, the negative staining was also ob-
served in some types of cells (Figure 2). Analysis of the
sections showed that TEX101 was highly expressed in
spermatocytes and spermatids but relatively expressed at
low levels in spermatogonia that were near the outer edge
of the seminiferous tubules (Figure 2). It is known that the
maturation of male germ cells follows the course from
spermatogonia to spermatocytes and finally spermatids.
Our finding confirmed TEX101 should be related to the
maturation process of germ cells and be considered a bio-
marker for the later stage of development.
Western blotting analysis of TEX101 in testis
Western blotting was also performed to analyze the ex-
pression features of TEX101. The tissue proteins from
three different individuals were subjected to Western blot-
ting and showed accordant features. For human testis
tissues, a single, specific band of 38 kDa was detected by aunohistochemistry was performed to examine 28 types of tissues
wide range, including cardiac muscle, lung, kidney, spleen, liver,
uterine cervix, endometrium, breast, testis, prostate, hypophysis, thyroid
llum, eye, peripheral nerves, and skin. The tissues sections were
DM2500 microscope (200×). Clear and strong staining was observed
Figure 2 Expression characteristics of TEX101 in testis. The tissue localization of TEX101 in testis was investigated through
immunohistochemistry. Strong staining of TEX101 was found in seminiferous tubules, but not in the connective tissue of testis (50×). In
seminiferous tubules, TEX101 was highly expressed in spermatocytes and spermatids, but not in spermatogonia (400×).
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no band was detected in mouse testis examined under the
same experimental conditions (Figure 3). It is interesting
that no band appeared at 21 kDa, which is the predicted
molecular weight of the mature TEX101 protein. These
results disclosed the actual molecular weight of TEX101
in human testis tissues and confirmed the human specifi-
city of this TEX101 antibody.
Structure prediction showed that human and mouse
TEX101 both possess a UPAR/Ly6 domain. However,
only 60% homology was found in the amino acid se-
quences of the two proteins. This relatively low hom-
ology suggested that there was a greater evolutionary
variation and there could be different functions betweenFigure 3 Western blotting analysis of TEX101 in testis. TEX101
expression in human and mouse testis was examined by Western
blotting. In human testis tissues, a single, specific band of 38 kDa
was detected, while no band appeared at 21 kDa. In mouse testis,
no band was detected under the same experimental conditions.human and mouse TEX101. The actual molecular
weight of TEX101 was determined to be 38 kDa, which
is much larger than its predicted molecular weight,
and this difference in size could result from post-
translational modification [18,19]. Bioinformatics ana-
lysis showed that the human TEX101 protein contains
one GPI anchor site (Asn-222) and two glycosylation
sites (Asn-45 and Asn-159). These modifications could
lead to variations in structure and electrical charge,
which might also contribute to the increased mobility of
TEX101 on the gel [20,21].
Disappearance of TEX101 in testicular cancer
Because high expression of TEX101 was detected in testis,
we also wanted to know if its expression changed in tes-
ticular cancer. Thirty-eight testicular cancer tissues, in-
cluding 36 samples of seminoma and two samples of yolk
sac tumor and embryonal carcinoma, were subjected to
immunohistochemistry. The sections showed that none of
the testicular cancer tissues showed staining for TEX101,
resulting in 100% negative expression (Figure 4). In con-
trast, all 10 samples of normal testis tissues that were col-
lected in this study were confirmed to possess strong
staining of TEX101, resulting in 100% positive expression
(Figure 4).
Previous studies demonstrated that TEX101 could
reduce the activities of uPA, MMPs and cathepsin B,
leading to the suppression of cell growth and migration
[12]. We speculated that the loss of TEX101 could
disrupt the metabolic balance of the above-mentioned
enzymes in the germinal epithelium, which could con-
tribute to the growth and migration of mutant cancer
cells. Therefore, our research not only found a poten-
tial biomarker for the diagnosis of testicular cancer but
also provided a potential molecular mechanism for the
progression of testicular cancer. However, for testicular
cancer in men who do not have a germ cell line (e.g.
Sertoli cell only syndrome), TEX101 should not be a
Figure 4 Expression analysis of TEX101 in testicular cancer. TEX101 expression in seminoma, yolk sac tumor, embryonal carcinoma, and
normal testis tissue were examined using immunohistochemistry. The sections showed no staining of TEX101; however, all collected normal testis
tissues possessed strong staining of TEX101, resulting in 100% positive expression.
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TEX101 in head and neck squamous cell carcinoma
(HNSCC) as well as in nasopharyngeal carcinoma and
chronic myeloid leukemia [10-12], which indicated
that TEX101 could be related to cancer progression.Conclusions
In summary, the differential expression of TEX101 that
was revealed in this study provided a valuable reference for
understanding the biological functions of TEX101. The
loss of TEX101 expression in seminoma also suggested its
potential role in the progression of testicular cancer.Methods
Materials
The primary antibodies were purchased from Atlas
(rabbit anti-TEX101, R38320) and Santa Cruz (mouse
anti-beta-actin, sc-81178). The secondary antibodies,
including goat anti-rabbit IgG (ZB-2301) and goat anti-
mouse IgG (ZB-2305), were purchased from ZSGB-Bio.
The Immobile Western chemiluminescent HRP sub-
strate (WBKLS01000) was purchased from Millipore.
The antibodies used for immunohistochemistry (bio-
tinylated anti-rabbit IgG, ZB-2010) and horseradishperoxidase-labeled streptavidin (ZB-2404) were pur-
chased from ZSGB-Bio.
Animal and human tissue samples
Three BALB/c mice were obtained from the Animal Center
of Sichuan University. A total of 38 samples of testicular
cancer tissue, 10 samples of normal testis tissue, and differ-
ent organs samples from 3 different human individuals
were from West China Hospital of Sichuan University. Col-
lected tissues samples were numbered and fixed in formalin
(4%) for 3 days, and the fixed samples were then washed
with water for 2 h, and dehydrated with a graded ethanol
series (75%, 85%, 95% and 100%) for 1 h each. Then, the
samples were infiltrated with xylene for 1 h and embedded
in paraffin blocks. The tissue was cut into 4 μm-thick sec-
tions, which were then placed on highly adhesive slides.
The sections were stored at 4°C until the subsequent exper-
iments were performed. This study was approved by the in-
stitutional ethics committee of Sichuan University. All of
the patients assented to participate in the study after pro-
viding informed consent.
Immunohistochemistry
Immunohistochemistry was performed using the SP
(streptavidin-peroxidase) method. Briefly, the sections
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bated with 3% H2O2 for 10 min, and blocked in 5% BSA
for 10 min at room temperature. The sections were then
probed with the primary antibody against TEX101 (1:300,
diluted with PBS) overnight at 4°C. Subsequently, the sec-
tions were washed with PBS three times and incubated
with biotinylated anti-rabbit IgG for 30 min at 37°C. After
washing three times, the sections were incubated with
horseradish peroxidase-labeled streptavidin for 30 min at
37°C and then washed four times with PBS. Finally, the
sections were visualized using diaminobenzidine (DAB).
Images were captured (200× and 400×) using high-
resolution microscopy (Leica DM2500 microscope) and
analyzed using Leica Application Suite software.
Western blotting
The collected tissue samples of human and mouse testis
were ground in liquid nitrogen, lysed in RIPA Buffer for
30 min on ice, and centrifuged at 16,000 g for 30 min at
4°C. After measurement using a Protein Assay kit (Bio-
Rad), the proteins were separated on 12% SDS-PAGE gels
and transferred to PVDF membranes (Bio-Rad, 162–0177).
The membranes were blocked in TBST (20 mM Tris
(pH 7.5), 150 mM NaCl, and 0.1% Tween 20) that con-
tained 5% skimmed milk for 3 h at 37°C and then incu-
bated with the primary antibodies against TEX101 (1:1000,
diluted by TBST) for 2 h at 37°C. Subsequently, the mem-
branes were washed three times with TBST and probed
with secondary antibodies conjugated to HRP (1:15000, di-
luted by TBST) for 1 h at 37°C. After washing three times,
the membranes were developed using the Immobilon
Western kit (chemiluminescent HRP substrate) (Millipore).
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